Canty, Allan J.; Stevens, Elizabeth A. published the article 《Synthesis of potential platinum(II) antitumor complexes: complexes containing bidentate pyridyl and imidazolyl donors》. Keywords: antitumor platinum dipyridylmethane pyridylimidazole complex; imidazole pyridyl platinum antitumor complex.They researched the compound: cis-Dichlorobis(pyridine)platinum(II)( cas:15227-42-6 ).Recommanded Product: 15227-42-6. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:15227-42-6) here.
PtLCl2 [L = di-2-pyridylmethane, 3,3-bis(2-pyridyl)pentane, 2-(2-pyridyl)imidazole (I), N-methyl-2-(2-pyridyl)imidazole] were prepared and characterized by chem. anal., elec. conductivity, IR spectra, and inhibitory effects on cultures of L1210 mouse leukemia cells. The complex with L = I gave a 50% inhibiting dose similar to that of cis-Pt(NH3)2Cl2 and below the values of the other complexes; this suggests that further tests with tumor-bearing animals is warranted for this I complex with Pt.
When you point to this article, it is believed that you are also very interested in this compound(15227-42-6)Recommanded Product: 15227-42-6 and due to space limitations, I can only present the most important information.
Reference:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem